| Financial Year |
March 31 2023 |
| Monetary Funds |
824,972,475.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,351,824.51 |
| Accounts Receivable |
17,388,104.57 |
| Advances to Suppliers |
27,648,309.98 |
| Other Receivables |
41,101,037.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
181,993,769.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,188,818,345.14 |
| Total Current Assets |
2,284,273,866.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
921,368,103.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
233,093,703.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
33,046,298.79 |
| Deferred Income Tax Assets |
66,609,606.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,033,360,675.28 |
| Total Assets |
5,317,634,542.11 |
| Short-Term Loans |
110,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
454,553,000.00 |
| Accounts Payable |
152,020,349.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,786,431.94 |
| Taxes Payable |
28,836,486.69 |
| Interest Payable |
-- |
| Dividend Payable |
300,865.10 |
| Other payables |
138,373,387.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
99,368,592.85 |
| Other Current Liabilities |
6,737,695.99 |
| Sub-Total of Current Liabilities |
1,063,113,372.99 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,650,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
264,529,648.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
774,840,951.39 |
| Total Liabilities |
1,837,954,324.38 |
| Paid-In Capital(Or Share Stock) |
543,582,655.00 |
| Capital Surplus |
417,394,285.30 |
| Surplus Reserve |
197,467,977.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,316,543,107.51 |
| Minority Stockholder's Interest |
295,697,405.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,183,982,812.37 |
| Owner's Equity（Stockholder's Equity） |
3,479,680,217.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,317,634,542.11 |
